Correspondence 0001193125-26-201422 from Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc
Date: May 1, 2026 · CIK: 0001730463 · Accession: 0001193125-26-201422
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295003
Letter
Re: Autolus Therapeutics plc Registration Statement on Form S-3 File No. 333-295003 Acceleration Request Requested Date: May 5, 2026 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) to become effective on May 5, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Christian Plaza, Courtney Thorne and William DuVal of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with William DuVal of Cooley LLP at (703) 456-8663, or in his absence, Courtney Thorne at (617) 937-2318. Thank you for your assistance with this matter.
The MediaWorks 191 Wood Lane White City London W12 7FP United Kingdom
VIA EDGAR May 1, 2026 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Sincerely,
AUTOLUS THERAPEUTICS PLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP The MediaWorks 191 Wood Lane White City London W12 7FP United Kingdom VIA EDGAR May 1, 2026 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Autolus Therapeutics plc Registration Statement on Form S-3 File No. 333-295003 Acceleration Request Requested Date: May 5, 2026 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) to become effective on May 5, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Christian Plaza, Courtney Thorne and William DuVal of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with William DuVal of Cooley LLP at (703) 456-8663, or in his absence, Courtney Thorne at (617) 937-2318. Thank you for your assistance with this matter. Sincerely, AUTOLUS THERAPEUTICS PLC By: /s/ Christian Itin Christian Itin Chief Executive Officer cc: Alex Driggs, Autolus Therapeutics plc Christian Plaza, Cooley LLP Courtney Thorne, Cooley LLP William DuVal, Cooley LLP